Osimertinib Recruiting Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC)

IndicationsStatusPurposePhase
RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03790397Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive